检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

LBA88 Belzutifan versus everolimus in participants (pts) with previously treated advanced clear cell renal cell carcinoma (ccRCC): Randomized open-label phase III LITESPARK-005 study

L. Albiges, B.I. Rini,K. Peltola,G.A. De Velasco Oria,M. Burotto,C. Suarez Rodriguez,P. Ghatalia,R. Iacovelli,E.T. Lam,E. Verzoni, M. Gumus,W.M. Stadler,C.K. Kollmannsberger,B. Melichar, B. Venugopal, A. Wang, R. Perini, D. Vickery,T.B. Powles,T.K. Choueiri

Annals of Oncology（2023）

引用 0|浏览4
暂无评分
关键词
renal cell carcinoma,everolimus,lba88 belzutifan,open-label
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要